India’s Strength.
Your Advantage.
Our Expertise.

India has rapidly emerged as a global powerhouse for pharmaceuticals and specialty chemicals. With rising global demand, supply‑chain diversification, and increasing regulatory alignment, India is the right partner at the right time.
Here’s why global companies are turning to India:

1. World‑Class Manufacturing at Competitive Costs
   India offers high‑quality production at significantly lower costs compared to Western countries or China — without compromising on compliance or quality.

2. Strong Regulatory Infrastructure
   India is home to the largest number of USFDA‑approved pharma plants outside the USA. Manufacturers are well‑versed in global standards such as EU‑GMP, WHO‑GMP, and REACH compliance, ensuring smooth market entry.

3. Skilled Talent & Technical Depth
   A vast pool of scientists, process engineers, and regulatory experts gives India an edge in handling complex chemistry, technology transfers, and product development.

4. Government Support & Policy Push
   Initiatives like ‘Make in India’, PLI schemes, and export incentives are accelerating growth and attracting investment in pharmaceuticals, APIs, and specialty chemicals.

5. Supply Chain Diversification is a Global Priority
   The world is moving away from over‑dependence on single‑country sourcing. India offers a stable, transparent, and scalable alternative, making it a key player in global supply‑chain strategies.

6. Rapid Scale‑Up & Partnership Potential
   From pilot to commercial scale, India’s ecosystem is designed to grow with you. Whether you're seeking CDMOs, CMOs, or R&D collaborators, India has the capacity and readiness to deliver.
   
   India is no longer just an option—it’s a strategic imperative. And with a trusted partner like Dhanvi EGLS, you get more than access; you get expertise, insight, and reliable execution on the ground.
   
   Let’s build the future of global sourcing—from India to the world.